Clinical Trial Update: An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral azacitidine (CC-486) as maintenance therapy for Chinese participants with acute myeloid leukemia in complete remission; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CC-486 (oral azacitidine) (azacitidine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: ACTIVE_NOT_RECRUITING